Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Held

Showing results (91-100 of 227) with videos related to

Pageof 23
Sort By:
American Heart Journal|January 3, 2020
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialDavid A Garcia, Deborah A Fisher, Hillary Mulder, et al.
American Heart Journal|March 17, 2022
Independence of clinical events committees: A consensus statement from clinical research organizationsErnest Spitzer, Alexander C Fanaroff, C Michael Gibson, et al.
European Journal of Preventive Cardiology|July 28, 2019
Cardiac rehabilitation after acute myocardial infarction in Sweden - evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) studyHalldora Ögmundsdottir Michelsen, Ingela Sjölin, Mona Schlyter, et al.
American Heart Journal|June 2, 2015
Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialHyun-Jae Kang, Robert M Clare, Runlin Gao, et al.
European Heart Journal|April 26, 2016
Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart diseaseRalph A H Stewart, Lars Wallentin, Jocelyne Benatar, et al.
JAMA Cardiology|August 25, 2021
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary SyndromeGorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, et al.
American Heart Journal|December 21, 2018
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trialClaes Held, Harvey D White, Ralph A H Stewart, et al.
American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.
Pageof 23

Showing results (91-100 of 227) with videos related to

Sort By:
Pageof 23
American Heart Journal|January 3, 2020
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialDavid A Garcia, Deborah A Fisher, Hillary Mulder, et al.
American Heart Journal|March 17, 2022
Independence of clinical events committees: A consensus statement from clinical research organizationsErnest Spitzer, Alexander C Fanaroff, C Michael Gibson, et al.
European Journal of Preventive Cardiology|July 28, 2019
Cardiac rehabilitation after acute myocardial infarction in Sweden - evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) studyHalldora Ögmundsdottir Michelsen, Ingela Sjölin, Mona Schlyter, et al.
American Heart Journal|June 2, 2015
Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialHyun-Jae Kang, Robert M Clare, Runlin Gao, et al.
European Heart Journal|April 26, 2016
Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart diseaseRalph A H Stewart, Lars Wallentin, Jocelyne Benatar, et al.
JAMA Cardiology|August 25, 2021
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary SyndromeGorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, et al.
American Heart Journal|December 21, 2018
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trialClaes Held, Harvey D White, Ralph A H Stewart, et al.
American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.
Pageof 23